• About Us  
    • Our Mission
    • Company Profile
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • ProTcell platform
  • Pipeline
  • News 
    • Press releases
    • Smart Stories
  • Partnering
  • Contact

Press Releases

All
Smart Stories
All
Press Releases
All
Factsheets

PRO-THYMUS: a groundbreaking solution to restore the immune system in AML patients, laureate of the Eurostars 3 program

July 11, 2023

Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101 at the European Hematology Association (EHA)

May 11, 2023

Smart Immune receives $5 million investment to further its thymus-empowered ProTcell therapy platform

April 17, 2023

Smart Immune receives €2.5m grant and €15m equity investment commitment from the European Innovation Council (EIC) via the EIC Accelerator

March 30, 2023

Smart Immune is selected for the first cohort of the French Tech Health20 program

March 24, 2023

1st leukemia patient dosed with SMART101 at MSK

January 23, 2023
←
Previous
Next
→
© 2021 Smart Immune SAS
Legal NoticeFAQ
